IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
195 hedge funds and large institutions have $2.4B invested in Impax Laboratories, Inc. in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 68 increasing their positions, 80 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $3.16B → $2.4B (-$760M)
25% less call options, than puts
Call options by funds: $3.93M | Put options by funds: $5.28M
Holders
195
Holding in Top 10
7
Calls
$3.93M
Puts
$5.28M
Top Buyers
| 1 | +$52.7M | |
| 2 | +$26.6M | |
| 3 | +$21.4M | |
| 4 |
AG
Aravt Global
New York
|
+$15.7M |
| 5 |
BP
Banbury Partners
Charlotte,
North Carolina
|
+$10.9M |
Top Sellers
| 1 | -$38.7M | |
| 2 | -$25.3M | |
| 3 | -$19.7M | |
| 4 |
BJCM
Blue Jay Capital Management
Los Angeles,
California
|
-$14.9M |
| 5 |
SCA
Southpoint Capital Advisors
New York
|
-$10.6M |